Core Insights - Merus NV's shares increased by 38.2% to $95.21 following Genmab's announcement of an $8 billion all-cash acquisition deal, which includes the addition of the breakthrough therapy Petosemtamab to Genmab's late-stage pipeline [1] Gainers - Steakholder Foods Ltd rose 92% to $8.32 after announcing an agreement to acquire Twine Solutions [4] - JFB Construction Holdings surged 77.4% to $12.15 following a $44 million private placement announcement [4] - Plus Therapeutics gained 24.3% to $0.77 after securing a national coverage agreement with UnitedHealthcare for its CNSide assay [4] - Avalo Therapeutics rose 24.1% to $13.40 after a previous decline of 6% [4] - Enanta Pharmaceuticals gained 22.7% to $9.69 ahead of presenting topline results from its Phase 2b study of Zelicapavir for RSV [4] - Canopy Growth Corp jumped 19.4% to $1.60 [4] - Zura Bio Ltd gained 18.3% to $2.85 after a 15% increase on Friday [4] - Tilray Brands surged 17.4% to $1.35, with first-quarter financial results to be announced on October 9 [4] - Larimar Therapeutics jumped 16.4% to $5.93, with an update on the Nomlabofusp program scheduled for September 2 [4] Losers - MoonLake Immunotherapeutics dipped 86.3% to $8.50 despite achieving statistically significant results in its Phase 3 VELA trials [4] - Maris Tech fell 37.3% to $2.62 after reporting a H1 loss of 30 cents per share [4] - Sunrise New Energy Co Ltd shares dipped 28.1% to $0.88 after a previous 10% gain [4] - Cycurion Inc declined 15.5% to $0.28 after a significant drop of over 30% on Friday [4] - bioAffinity Technologies dipped 14.4% to $4.53 after a 55% increase on Friday [4] - Youxin Technology Ltd fell 13.9% to $0.058 following a 1-for-80 reverse split announcement [4] - Top KingWin Ltd declined 12.8% to $4.07 after a previous 48% increase [4] - Cellectis SA fell 10.4% to $3.01 [4] - Quantum-Si Inc decreased 10.1% to $1.34 after filing for a mixed shelf of up to $300 million [4] - Penguin Solutions Inc fell 8.4% to $24.00 [4]

Core Insights - Steakholder Foods Ltd. has received a positive Written Opinion from the International Searching Authority regarding its international patent application for the HD144 printer, which focuses on plant-based fish production [1][2] - The ISA confirmed that all 21 claims in the application meet the criteria of novelty, inventive step, and industrial applicability, highlighting the innovative nature of the company's technology [2] - The patented system features a multi-component architecture for bio-ink management, gas pressure control, and a central processing module, essential for producing high-fidelity plant-based fish products [3] Technology Overview - The DLS® (Drop Location in Space) technology allows for ultra-precise deposition of plant-based materials, enabling realistic structuring and marbling that mimics conventional fish [4] - The HD144 printer is designed specifically for producing structured plant-based seafood, raising standards in the alternative protein sector [5] Strategic Implications - The positive opinion from the ISA is a significant milestone for the company, reinforcing its intellectual property strength and supporting its global commercialization and partnership strategies [5] - The company is positioned to pursue national phase filings in key global markets, enhancing its leadership in the 3D-printed alternative protein industry [5] Company Background - Founded in 2019, Steakholder Foods specializes in 3D-printing technology for alternative protein production, focusing on high-quality raw ingredients to meet consumer expectations [6] - The company aims to replicate the complex textures of traditional meats and is exploring the integration of cultivated cells for future advancements in food technology [7]

Core Points - Steakholder Foods Ltd. announced a change in the ratio of its American Depositary Shares (ADSs) from one ADS representing one hundred ordinary shares to one ADS representing five hundred ordinary shares, effective April 28, 2025 [1][2] - This adjustment will be executed as a one-for-five reverse ADS split, requiring no action from existing ADS holders [2] - The Bank of New York Mellon will facilitate the exchange of existing ADSs for the new ratio on the effective date [2] - No new ADSs will be issued in connection with this adjustment, and any fractional shares will be aggregated and sold, with net proceeds distributed to ADS holders [3] Company Overview - Steakholder Foods is a leader in 3D-printed meat and fish technology, focusing on cultivated cell innovation [1] - Founded in 2019, the company specializes in developing 3D-printing production machines and proprietary premix blends made from high-quality raw ingredients [4] - The company's technology aims to help manufacturers produce alternative proteins that meet consumer expectations for taste, texture, and appearance, providing a sustainable alternative to traditional meat and seafood production [4] - Steakholder Foods is also working on replicating the textures of traditional meats and exploring the integration of cultivated cells for future advancements in food technology [5]

Core Insights - Steakholder Foods Ltd. is a leader in 3D-printed meat and fish technology, showcasing significant advancements in technology and market presence [1] - The company initiated revenue generation in 2024 through a commercial sales agreement with Bondor Foods Ltd., marking a crucial step in its commercialization strategy [2] - The company has received multiple purchase orders for its proprietary premix blends, indicating its versatility in the alternative protein sector [3] Business Highlights - In 2024, Steakholder Foods generated initial revenues of $10 thousand, with a gross loss of $22 thousand [7] - The company decreased its research and development expenses to $3.5 million in 2024 from approximately $7.1 million in 2023, primarily due to reduced payroll and share-based compensation [7] - Marketing expenses also decreased to $1.4 million in 2024 from approximately $2.7 million in 2023, reflecting cost-cutting measures [8] Financial Performance - The loss from continuing operations decreased to $8.5 million in 2024 from approximately $15.5 million in 2023, driven by reduced research and development expenses [10] - Net cash used in operating activities decreased to $8.5 million in 2024 from approximately $12.7 million in 2023 [11] - Cash and equivalents at year-end 2024 was $1.3 million, down from $4.2 million at year-end 2023 [12] Strategic Developments - The company opened its first full-scale Demonstration Center to showcase its 3D printing technologies, allowing potential clients to experience the production process [5] - Partnerships with organizations like the Industrial Technology Research Institute (ITRI) and Sherry Herring Sandwiches Ltd. are driving expansion and product development tailored to local markets [4] Fundraising Activities - In February 2025, the company entered into a securities purchase agreement, raising $1.25 million through the sale of 1,097,358 ADSs at $1.1391 per ADS [6] - An At-the-Money Offering Agreement was established, allowing the company to access up to $8 million in equity over the duration of the agreement [6]

Core Viewpoint - Steakholder Foods Ltd. has entered into definitive agreements for a private placement with Alumni Capital LP, raising approximately $1.25 million through the sale of American Depositary Shares (ADSs) and warrants, aimed at supporting its strategic growth initiatives [1][2][4]. Group 1: Private Placement Details - The company will sell 985,028 ADSs at a purchase price of $1.269 per ADS, with warrants to purchase an equal number of ADSs at an exercise price of $2.00, which will be immediately exercisable and expire in five years [1][2]. - The gross proceeds from this offering are expected to be around $1.25 million before deducting offering expenses, with the net proceeds intended for working capital and general corporate purposes [2]. Group 2: Equity Line of Credit - Steakholder Foods has established an equity line of credit (ELOC) with Alumni Capital LP, providing a flexible funding mechanism to support its growth while minimizing dilution to existing shareholders [4][5]. - The structure of the ELOC allows the company to maintain control over the timing and amount of equity sales, ensuring financial stability and strategic flexibility [5]. Group 3: Management Commentary - The CEO of Steakholder Foods emphasized that the agreements with Alumni Capital represent a significant milestone in the company's growth strategy, providing immediate funds for continued strategic growth while mitigating dilution [6]. - The Portfolio Manager at Alumni Capital expressed confidence in the company's vision and management team, indicating a commitment to support Steakholder Foods in driving sustainable value creation [6]. Group 4: Company Overview - Steakholder Foods specializes in alternative proteins and 3D printing technologies, focusing on developing and selling production machines that enable efficient food manufacturing [8]. - The company aims to create products that replicate the textures of traditional meats and is exploring the integration of cultivated cells for future advancements in food technology [9].